Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marc de Perrot

Showing results (271-280 of 333) with videos related to

Pageof 34
Sort By:
The Journal of Thoracic and Cardiovascular Surgery|July 30, 2020
Deceased-donor lobar lung transplant: A successful strategy for small-sized recipientsJose Luis Campo-Canaveral De La Cruz, Ben Dunne, Philippe Lemaitre, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|March 23, 2024
The International Association for the Study of Lung Cancer Mesothelioma Staging Project: Proposals for Revisions of the "T" Descriptors in the Forthcoming Ninth Edition of the TNM Classification for Pleural MesotheliomaRitu R Gill, Anna K Nowak, Dorothy J Giroux, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 12, 2024
Secondary Analysis of the Rate of Second Primary Lung Cancer From Cancer and Leukemia Group B 140503 (Alliance) Trial of Lobar Versus Sublobar Resection for T1aN0 Non-Small-Cell Lung CancerThomas E Stinchcombe, Xiaofei Wang, Bryce Damman, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|February 24, 2016
Plasma Biomarker Enrichment of Clinical Prognostic Indices in Malignant Pleural MesotheliomaHarvey I Pass, Chandra Goparaju, Osvaldo Espin-Garcia, et al.
The New England Journal of Medicine|October 12, 2012
Fibulin-3 as a blood and effusion biomarker for pleural mesotheliomaHarvey I Pass, Stephen M Levin, Michael R Harbut, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 26, 2010
Soluble mesothelin-related Peptide and osteopontin as markers of response in malignant mesotheliomaPaul Wheatley-Price, Boming Yang, Demetris Patsios, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|January 7, 2014
Long-term outcome after en bloc resection of non-small-cell lung cancer invading the pulmonary sulcus and spineStéphane Collaud, Thomas K Waddell, Kazuhiro Yasufuku, et al.
The Annals of Thoracic Surgery|October 24, 2024
Characteristics of Long-term Survivors With Malignant Pleural MesotheliomaIsabelle Opitz, Olivia Lauk, Raphael Werner, et al.
The Annals of Thoracic Surgery|June 25, 2025
Intraoperative Surgical Margin Assessment of Sublobar Lung Resection Specimens Using Computed TomographyShinsuke Kitazawa, Nicholas Bernards, Yuki Sata, et al.
Clinical Lung Cancer|September 17, 2021
Treatment Patterns and Outcomes of Patients With Advanced Pleural Mesothelioma at an Academic Referral CentreSabine Schmid, Luna Zhan, Kristen Dietrich, et al.
Pageof 34

Showing results (271-280 of 333) with videos related to

Sort By:
Pageof 34
The Journal of Thoracic and Cardiovascular Surgery|July 30, 2020
Deceased-donor lobar lung transplant: A successful strategy for small-sized recipientsJose Luis Campo-Canaveral De La Cruz, Ben Dunne, Philippe Lemaitre, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|March 23, 2024
The International Association for the Study of Lung Cancer Mesothelioma Staging Project: Proposals for Revisions of the "T" Descriptors in the Forthcoming Ninth Edition of the TNM Classification for Pleural MesotheliomaRitu R Gill, Anna K Nowak, Dorothy J Giroux, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 12, 2024
Secondary Analysis of the Rate of Second Primary Lung Cancer From Cancer and Leukemia Group B 140503 (Alliance) Trial of Lobar Versus Sublobar Resection for T1aN0 Non-Small-Cell Lung CancerThomas E Stinchcombe, Xiaofei Wang, Bryce Damman, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|February 24, 2016
Plasma Biomarker Enrichment of Clinical Prognostic Indices in Malignant Pleural MesotheliomaHarvey I Pass, Chandra Goparaju, Osvaldo Espin-Garcia, et al.
The New England Journal of Medicine|October 12, 2012
Fibulin-3 as a blood and effusion biomarker for pleural mesotheliomaHarvey I Pass, Stephen M Levin, Michael R Harbut, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 26, 2010
Soluble mesothelin-related Peptide and osteopontin as markers of response in malignant mesotheliomaPaul Wheatley-Price, Boming Yang, Demetris Patsios, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|January 7, 2014
Long-term outcome after en bloc resection of non-small-cell lung cancer invading the pulmonary sulcus and spineStéphane Collaud, Thomas K Waddell, Kazuhiro Yasufuku, et al.
The Annals of Thoracic Surgery|October 24, 2024
Characteristics of Long-term Survivors With Malignant Pleural MesotheliomaIsabelle Opitz, Olivia Lauk, Raphael Werner, et al.
The Annals of Thoracic Surgery|June 25, 2025
Intraoperative Surgical Margin Assessment of Sublobar Lung Resection Specimens Using Computed TomographyShinsuke Kitazawa, Nicholas Bernards, Yuki Sata, et al.
Clinical Lung Cancer|September 17, 2021
Treatment Patterns and Outcomes of Patients With Advanced Pleural Mesothelioma at an Academic Referral CentreSabine Schmid, Luna Zhan, Kristen Dietrich, et al.
Pageof 34